• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双膦酸盐相关性颌骨坏死:临床病理研究与组织形态计量分析。

Bisphosphonate related osteonecrosis of the jaws: clinico-pathological investigation and histomorphometric analysis.

机构信息

Department of Periodontics, Hebrew University-Hadassah School of Dental Medicine, Jerusalem, Israel.

出版信息

Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 May;115(5):660-6. doi: 10.1016/j.oooo.2013.03.001.

DOI:10.1016/j.oooo.2013.03.001
PMID:23601221
Abstract

OBJECTIVES

Clinico-pathological evaluation of bisphosphonate (BP)-related osteonecrosis of jaws, comparison between oral (PO) and intravenous (IV) BPs and histomorphometric analysis of associated actinomyces.

STUDY DESIGN

Retrospective clinical and histomorphometric analysis. Data on background, clinical, treatment and follow-up were analyzed. Actinomyces colonies were identified by typical filamentous colony morphology, Gram, and PAS stains. Colony density and relative colony surface area were measured.

RESULTS

Fifty-two patients were included, 37 (71.2%) IV, 15 (28.8%) PO BPs. with a mean duration of 2.33 and, 4.33 years respectively. One hundred percent of cases exhibited actinomyces colonization. The relative colony surface area was significantly higher in PO treatment (P = .024), with no differences in density, healing time or antibiotic treatment periods. High frequency of diabetes mellitus (60% PO cases) and corticosteroid treatment (25% of cases) were recorded.

CONCLUSION

Infection with actinomyces is a common denominator in BP-related osteonecrosis of the jaws (BRONJ), regardless of administration route. Diabetes and corticosteroid treatment seem to be important contributing factors for BRONJ.

摘要

目的

对双膦酸盐(BP)相关下颌骨坏死进行临床病理评估,比较口服(PO)和静脉内(IV)BP 以及相关放线菌的组织形态计量学分析。

研究设计

回顾性临床和组织形态计量学分析。分析背景、临床、治疗和随访数据。通过典型的丝状菌落形态、革兰氏和 PAS 染色鉴定放线菌菌落。测量菌落密度和相对菌落表面积。

结果

共纳入 52 例患者,37 例(71.2%)为 IV 组,15 例(28.8%)为 PO 组,平均治疗时间分别为 2.33 年和 4.33 年。100%的病例均有放线菌定植。PO 治疗的相对菌落表面积显著更高(P=0.024),但菌落密度、愈合时间或抗生素治疗期无差异。记录到糖尿病(PO 组 60%)和皮质类固醇治疗(25%的病例)的高频率。

结论

无论给药途径如何,感染放线菌都是双膦酸盐相关下颌骨坏死(BRONJ)的共同决定因素。糖尿病和皮质类固醇治疗似乎是 BRONJ 的重要促成因素。

相似文献

1
Bisphosphonate related osteonecrosis of the jaws: clinico-pathological investigation and histomorphometric analysis.双膦酸盐相关性颌骨坏死:临床病理研究与组织形态计量分析。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 May;115(5):660-6. doi: 10.1016/j.oooo.2013.03.001.
2
Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan.日本全国范围内双膦酸盐相关颌骨坏死的调查。
J Oral Maxillofac Surg. 2011 Nov;69(11):e364-71. doi: 10.1016/j.joms.2011.03.051. Epub 2011 Jul 23.
3
Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: a retrospective multi-hospital-based study of 87 Italian cases.口服双膦酸盐治疗骨质疏松症导致的颌骨骨坏死:87 例意大利多医院回顾性研究。
Eur J Intern Med. 2013 Dec;24(8):784-90. doi: 10.1016/j.ejim.2013.05.011. Epub 2013 Jun 12.
4
The clinical spectrum of Actinomyces-associated lesions of the oral mucosa and jawbones: correlations with histomorphometric analysis.口腔黏膜和颌骨放线菌相关病变的临床谱:与组织形态计量学分析的相关性
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Nov;108(5):738-46. doi: 10.1016/j.tripleo.2009.06.019. Epub 2009 Sep 12.
5
Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis.接受选定癌症或骨质疏松症治疗的双膦酸盐使用者的颌骨坏死发生率。
Pharmacoepidemiol Drug Saf. 2012 Aug;21(8):810-7. doi: 10.1002/pds.3292. Epub 2012 Jun 19.
6
Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.美国骨质疏松症和癌症患者的不良事件以及静脉注射与口服双膦酸盐的使用情况
Gen Dent. 2010 Nov-Dec;58(6):484-92; quiz 493-4.
7
Bisphosphonate-related osteonecrosis of jaw (BRONJ) in Japanese population: a case series of 13 patients at our clinic.日本人群中的双膦酸盐相关颌骨坏死(BRONJ):我们诊所13例患者的病例系列
Bull Tokyo Dent Coll. 2013;54(2):117-25. doi: 10.2209/tdcpublication.54.117.
8
Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons.安大略省的双膦酸盐相关性颌骨坏死:口腔颌面外科医生的调查。
J Rheumatol. 2011 Jul;38(7):1396-402. doi: 10.3899/jrheum.100221. Epub 2011 Apr 15.
9
[Bisphosphonate related osteonecrosis of the jaw and infection with Actinomyces].[双膦酸盐相关颌骨骨坏死与放线菌感染]
Med Clin (Barc). 2012 Dec 15;139(15):676-80. doi: 10.1016/j.medcli.2012.05.039. Epub 2012 Oct 25.
10
A study of 225 patients on bisphosphonates presenting to the bisphosphonate clinic at King's College Hospital.一项对 225 名在国王学院医院双膦酸盐诊所就诊的双膦酸盐患者进行的研究。
Br Dent J. 2013 Apr;214(7):E18. doi: 10.1038/sj.bdj.2013.327.

引用本文的文献

1
Clinical Effectiveness of Surgical Marginal Resection with Piezoelectric Device on Bisphosphonate-Related Osteonecrosis of the Jaws: A Retrospective Study.使用压电装置进行手术边缘切除治疗双膦酸盐相关颌骨骨坏死的临床疗效:一项回顾性研究。
J Clin Med. 2025 May 28;14(11):3792. doi: 10.3390/jcm14113792.
2
Medication-related osteonecrosis of the jaws: a series of 22 cases highlighting their histopathological features.药物相关性颌骨骨坏死:22例病例系列研究,重点突出其组织病理学特征
Braz Oral Res. 2025 Jun 2;39:e058. doi: 10.1590/1807-3107bor-2025.vol39.058. eCollection 2025.
3
Magnesium Nanocomposite Hydrogel Reverses the Pathologies to Enhance Mandible Regeneration.
镁纳米复合水凝胶逆转病理状态以促进下颌骨再生。
Adv Mater. 2025 Jan;37(2):e2312920. doi: 10.1002/adma.202312920. Epub 2024 Oct 10.
4
Targeted histological evaluation shows high incidence of actinomyces infection in medication-related osteonecrosis of the jaws.靶向组织学评估显示,药物相关性颌骨坏死中放线菌感染的发生率很高。
Sci Rep. 2022 Mar 1;12(1):3406. doi: 10.1038/s41598-022-07375-1.
5
Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment.接受口服与静脉注射双膦酸盐治疗的颌骨坏死患者的特征。
Maxillofac Plast Reconstr Surg. 2021 Jul 8;43(1):24. doi: 10.1186/s40902-021-00310-w.
6
Clinical analysis of medication related osteonecrosis of the jaws: A growing severe complication in China.颌骨药物相关性骨坏死的临床分析:中国一种日益严重的并发症
J Dent Sci. 2018 Sep;13(3):190-197. doi: 10.1016/j.jds.2017.12.003. Epub 2018 Feb 6.
7
Application of Autologous Platelet-Rich Plasma on Tooth Extraction Site Prevents Occurence of Medication-Related Osteonecrosis of the Jaws in Rats.富血小板血浆在拔牙创应用预防大鼠药物相关性颌骨坏死的发生。
Sci Rep. 2019 Jan 10;9(1):22. doi: 10.1038/s41598-018-37063-y.
8
"Holes" in the Jaw-A Report of Two Cases of Periapical Actinomycosis.颌骨中的“空洞”——两例根尖放线菌病报告
Diseases. 2018 Sep 6;6(3):79. doi: 10.3390/diseases6030079.
9
Diabetes Mellitus and Its Association to the Occurrence of Medication-Related Osteonecrosis of the Jaw.糖尿病及其与颌骨药物相关性骨坏死发生的关联。
Dent J (Basel). 2016 May 31;4(2):17. doi: 10.3390/dj4020017.
10
Serum levels of RANKL and OPG, and the RANKL/OPG ratio in bisphosphonate-related osteonecrosis of the jaw: Are they useful biomarkers for the advanced stages of osteonecrosis?双膦酸盐相关颌骨骨坏死中血清RANKL和OPG水平及RANKL/OPG比值:它们是否为骨坏死晚期的有用生物标志物?
Med Oral Patol Oral Cir Bucal. 2017 Sep 1;22(5):e542-e547. doi: 10.4317/medoral.22128.